Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01953211 · ClinicalTrials.gov registry record
Oral Contraceptive Hormone-free Interval Pituitary/ Ovarian Activity
A clinical trial of Hypothalamic-pituitary-ovarian Axis, Gonadotropins, Ethinyl Estradiol, Contraceptive Efficacy, sponsored by University of Southern California.
- Completed
- Registry status
- 64
- Enrollment target
- 1
- Study location
NCT01953211 is a study of Hypothalamic-pituitary-ovarian Axis, Gonadotropins, Ethinyl Estradiol, Contraceptive Efficacy that has completed, run by University of Southern California. The registered enrollment target is 64 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01953211, a study of Hypothalamic-pituitary-ovarian Axis, Gonadotropins, Ethinyl Estradiol, Contraceptive Efficacy, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The degree of suppression and subsequent activation of the hypothalamic-pituitary-ovarian axis during the hormone-free interval in combined oral contraceptive (COC) hormone users varies depending on the dose of ethinyl estradiol in the formulation. This variation in activation may be associated with different side effects during the hormone free interval. Progesterone (P) remained suppressed during all 6 COC regimens (\<1.8 ng/mL), which indicates continuous contraceptive efficacy during the 7-day hormone free interval of all formulations studied.
Conditions Studied
Interventions
- DRUG combined oral contraceptives
Study Locations (1)
California
- LAC and USC Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01953211
The ClinicalTrials.gov registry entry for NCT01953211 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypothalamic-pituitary-ovarian Axis, Gonadotropins, Ethinyl Estradiol, Contraceptive Efficacy appearing as the primary indexed condition, and to 1 intervention - of which combined oral contraceptives is the first listed.
NCT01953211 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01953211 about?
NCT01953211 is a clinical study titled "Oral Contraceptive Hormone-free Interval Pituitary/ Ovarian Activity". The degree of suppression and subsequent activation of the hypothalamic-pituitary-ovarian axis during the hormone-free interval in combined oral contraceptive (COC) hormone users varies depending on the dose of ethinyl estradiol in the formulation. This variation in activation may be associated with...
What is the current status of trial NCT01953211?
This trial is currently completed. The enrollment target is 64 participants.
What conditions does trial NCT01953211 study?
This clinical trial studies the following conditions: Hypothalamic-pituitary-ovarian Axis, Gonadotropins, Ethinyl Estradiol, Contraceptive Efficacy.
What interventions are being tested in trial NCT01953211?
The interventions under investigation include: combined oral contraceptives (DRUG).
Who is sponsoring clinical trial NCT01953211?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01953211 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.